HEADER SIGNALING PROTEIN 06-JAN-15 4XI3 TITLE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TITLE 2 BAZEDOXIFENE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 306-548, LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS ESTROGEN RECEPTOR, SERM, BAZEDOXIFENE, BREAST CANCER, NUCLEAR HORMONE KEYWDS 2 RECEPTOR, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.W.FANNING,C.G.MAYNE,W.TOY,K.CARLSON,B.GREENE,J.NOWAK,R.WALTER, AUTHOR 2 S.PANCHAMUKHI,E.TAJHORSHID,K.W.NETTLES,S.CHANDARLAPATY, AUTHOR 3 J.KATZENELLENBOGEN,G.L.GREENE REVDAT 5 06-MAR-24 4XI3 1 JRNL REMARK LINK REVDAT 4 27-SEP-23 4XI3 1 REMARK REVDAT 3 27-NOV-19 4XI3 1 REMARK REVDAT 2 10-APR-19 4XI3 1 HEADER REMARK REVDAT 1 13-JAN-16 4XI3 0 JRNL AUTH S.W.FANNING,R.JESELSOHN,V.DHARMARAJAN,C.G.MAYNE,M.KARIMI, JRNL AUTH 2 G.BUCHWALTER,R.HOUTMAN,W.TOY,C.E.FOWLER,R.HAN,M.LAINE, JRNL AUTH 3 K.E.CARLSON,T.A.MARTIN,J.NOWAK,J.C.NWACHUKWU,D.J.HOSFIELD, JRNL AUTH 4 S.CHANDARLAPATY,E.TAJKHORSHID,K.W.NETTLES,P.R.GRIFFIN, JRNL AUTH 5 Y.SHEN,J.A.KATZENELLENBOGEN,M.BROWN,G.L.GREENE JRNL TITL THE SERM/SERD BAZEDOXIFENE DISRUPTS ESR1 HELIX 12 TO JRNL TITL 2 OVERCOME ACQUIRED HORMONE RESISTANCE IN BREAST CANCER CELLS. JRNL REF ELIFE V. 7 2018 JRNL REFN ESSN 2050-084X JRNL PMID 30489256 JRNL DOI 10.7554/ELIFE.37161 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 33882 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.2054 - 5.7006 0.98 2683 150 0.2045 0.2645 REMARK 3 2 5.7006 - 4.5260 0.98 2709 134 0.2064 0.2726 REMARK 3 3 4.5260 - 3.9543 0.98 2695 145 0.1795 0.2312 REMARK 3 4 3.9543 - 3.5929 0.98 2702 140 0.1956 0.2122 REMARK 3 5 3.5929 - 3.3354 0.98 2699 143 0.2189 0.2704 REMARK 3 6 3.3354 - 3.1388 0.99 2681 159 0.2293 0.2716 REMARK 3 7 3.1388 - 2.9817 0.99 2716 130 0.2380 0.2757 REMARK 3 8 2.9817 - 2.8519 0.98 2712 163 0.2437 0.3374 REMARK 3 9 2.8519 - 2.7421 0.98 2741 134 0.2565 0.3322 REMARK 3 10 2.7421 - 2.6475 0.98 2708 144 0.2591 0.3244 REMARK 3 11 2.6475 - 2.5647 0.97 2655 132 0.2730 0.3108 REMARK 3 12 2.5647 - 2.4914 0.89 2477 130 0.2979 0.3484 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.950 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 7323 REMARK 3 ANGLE : 1.723 9945 REMARK 3 CHIRALITY : 0.044 1180 REMARK 3 PLANARITY : 0.006 1226 REMARK 3 DIHEDRAL : 13.591 2627 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XI3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000205724. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 6.6 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33882 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 2.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.45300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000, PHASER REMARK 200 STARTING MODEL: 2QXS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% PEG 3,350, 100 MM TRIS PH 6.6, 250 REMARK 280 MM MGCL2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PRO A 336 REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 GLU A 339 REMARK 465 ALA A 340 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 ALA A 546 REMARK 465 HIS A 547 REMARK 465 ARG A 548 REMARK 465 LEU B 306 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 ALA B 546 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 PHE C 461 REMARK 465 LEU C 462 REMARK 465 SER C 463 REMARK 465 SER C 464 REMARK 465 ALA C 546 REMARK 465 HIS C 547 REMARK 465 ARG C 548 REMARK 465 THR D 334 REMARK 465 ARG D 335 REMARK 465 PRO D 336 REMARK 465 PHE D 337 REMARK 465 SER D 338 REMARK 465 GLU D 339 REMARK 465 ALA D 340 REMARK 465 TYR D 459 REMARK 465 THR D 460 REMARK 465 PHE D 461 REMARK 465 LEU D 462 REMARK 465 SER D 463 REMARK 465 SER D 464 REMARK 465 THR D 465 REMARK 465 LEU D 466 REMARK 465 LYS D 467 REMARK 465 SER D 468 REMARK 465 LEU D 469 REMARK 465 GLU D 470 REMARK 465 LEU D 544 REMARK 465 ASP D 545 REMARK 465 ALA D 546 REMARK 465 HIS D 547 REMARK 465 ARG D 548 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 TYR A 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 332 CG OD1 OD2 REMARK 470 GLU A 397 CG CD OE1 OE2 REMARK 470 LYS A 401 CG CD CE NZ REMARK 470 ASP A 411 CG OD1 OD2 REMARK 470 ARG A 412 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLU A 423 CG CD OE1 OE2 REMARK 470 MET A 437 CG SD CE REMARK 470 THR A 460 OG1 CG2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 ARG A 477 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 523 CG CD OE1 OE2 REMARK 470 LYS A 529 CG CD CE NZ REMARK 470 CYS A 530 SG REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 ASN A 532 CG OD1 ND2 REMARK 470 ASP A 538 CG OD1 OD2 REMARK 470 GLU A 542 CG CD OE1 OE2 REMARK 470 GLN B 314 CG CD OE1 NE2 REMARK 470 TYR B 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 332 CG OD1 OD2 REMARK 470 THR B 334 OG1 CG2 REMARK 470 ARG B 363 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 411 CG OD1 OD2 REMARK 470 LYS B 416 CG CD CE NZ REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 LEU B 466 CG CD1 CD2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 470 LEU B 469 CG CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 ASP B 473 CG OD1 OD2 REMARK 470 ARG B 477 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 529 CG CD CE NZ REMARK 470 GLU B 542 CG CD OE1 OE2 REMARK 470 LEU C 306 CG CD1 CD2 REMARK 470 TYR C 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP C 332 CG OD1 OD2 REMARK 470 THR C 334 OG1 CG2 REMARK 470 ARG C 335 CG CD NE CZ NH1 NH2 REMARK 470 HIS C 377 CG ND1 CD2 CE1 NE2 REMARK 470 GLU C 397 CG CD OE1 OE2 REMARK 470 LYS C 401 CG CD CE NZ REMARK 470 ASP C 411 CG OD1 OD2 REMARK 470 LYS C 416 CG CD CE NZ REMARK 470 GLU C 419 CG CD OE1 OE2 REMARK 470 GLU C 423 CG CD OE1 OE2 REMARK 470 MET C 437 CG SD CE REMARK 470 LEU C 466 CG CD1 CD2 REMARK 470 LYS C 467 CG CD CE NZ REMARK 470 GLU C 470 CG CD OE1 OE2 REMARK 470 ASP C 473 CG OD1 OD2 REMARK 470 ARG C 477 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 489 CG CD1 CD2 REMARK 470 LYS C 529 CG CD CE NZ REMARK 470 LYS C 531 CG CD CE NZ REMARK 470 GLU C 542 CG CD OE1 OE2 REMARK 470 LEU D 306 CG CD1 CD2 REMARK 470 TYR D 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP D 332 CG OD1 OD2 REMARK 470 GLU D 380 CG CD OE1 OE2 REMARK 470 ASP D 411 CG OD1 OD2 REMARK 470 ARG D 412 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 416 CG CD CE NZ REMARK 470 GLU D 419 CG CD OE1 OE2 REMARK 470 GLU D 423 CG CD OE1 OE2 REMARK 470 MET D 437 CG SD CE REMARK 470 GLU D 471 CG CD OE1 OE2 REMARK 470 LYS D 472 CG CD CE NZ REMARK 470 ARG D 477 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 492 CG CD CE NZ REMARK 470 LYS D 529 CG CD CE NZ REMARK 470 CYS D 530 SG REMARK 470 LYS D 531 CG CD CE NZ REMARK 470 ASN D 532 CG OD1 ND2 REMARK 470 TYR D 537 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP D 538 CG OD1 OD2 REMARK 470 LEU D 539 CG CD1 CD2 REMARK 470 LEU D 540 CG CD1 CD2 REMARK 470 LEU D 541 CG CD1 CD2 REMARK 470 GLU D 542 CG CD OE1 OE2 REMARK 470 MET D 543 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND1 HIS A 524 OBC 29S A 601 1.31 REMARK 500 ND1 HIS D 524 OBC 29S D 601 1.32 REMARK 500 CE1 HIS D 524 OBC 29S D 601 1.91 REMARK 500 CE1 HIS A 524 OBC 29S A 601 2.00 REMARK 500 O LEU C 310 NZ LYS C 481 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG B 335 O ALA D 493 1465 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 333 CD PRO A 333 N 0.107 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 529 CB - CA - C ANGL. DEV. = -12.4 DEGREES REMARK 500 VAL C 458 CB - CA - C ANGL. DEV. = -13.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 408 59.89 -150.66 REMARK 500 MET A 528 -163.88 -106.25 REMARK 500 PRO B 333 -172.09 -60.48 REMARK 500 LEU B 408 64.60 -150.86 REMARK 500 MET B 528 -68.02 -101.58 REMARK 500 ALA C 307 -11.47 72.66 REMARK 500 ASP C 332 66.45 -114.29 REMARK 500 THR C 334 47.25 -92.98 REMARK 500 LEU C 408 49.74 -148.81 REMARK 500 GLU D 330 10.82 -68.20 REMARK 500 ASP D 332 62.13 -112.10 REMARK 500 LEU D 403 77.93 -101.26 REMARK 500 LEU D 408 59.32 -150.78 REMARK 500 ASN D 532 138.96 -175.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 331 ASP A 332 -148.72 REMARK 500 GLU B 330 TYR B 331 -141.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 716 DISTANCE = 5.90 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 29S A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 29S B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 29S C 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 29S D 601 and HIS D REMARK 800 524 DBREF 4XI3 A 306 548 UNP P03372 ESR1_HUMAN 306 548 DBREF 4XI3 B 306 548 UNP P03372 ESR1_HUMAN 306 548 DBREF 4XI3 C 306 548 UNP P03372 ESR1_HUMAN 306 548 DBREF 4XI3 D 306 548 UNP P03372 ESR1_HUMAN 306 548 SEQADV 4XI3 SER A 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 4XI3 SER A 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 4XI3 SER B 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 4XI3 SER B 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 4XI3 SER C 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 4XI3 SER C 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 4XI3 SER D 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 4XI3 SER D 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQRES 1 A 243 LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA SEQRES 2 A 243 LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR SEQRES 3 A 243 ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY SEQRES 4 A 243 LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET SEQRES 5 A 243 ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU SEQRES 6 A 243 THR SER HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP SEQRES 7 A 243 LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET SEQRES 8 A 243 GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU SEQRES 9 A 243 LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL SEQRES 10 A 243 GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE SEQRES 11 A 243 ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU SEQRES 12 A 243 LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE SEQRES 13 A 243 LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS SEQRES 14 A 243 ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE SEQRES 15 A 243 HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN SEQRES 16 A 243 HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS SEQRES 17 A 243 ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SEQRES 18 A 243 SER MET LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU SEQRES 19 A 243 LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 1 B 243 LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA SEQRES 2 B 243 LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR SEQRES 3 B 243 ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY SEQRES 4 B 243 LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET SEQRES 5 B 243 ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU SEQRES 6 B 243 THR SER HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP SEQRES 7 B 243 LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET SEQRES 8 B 243 GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU SEQRES 9 B 243 LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL SEQRES 10 B 243 GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE SEQRES 11 B 243 ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU SEQRES 12 B 243 LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE SEQRES 13 B 243 LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS SEQRES 14 B 243 ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE SEQRES 15 B 243 HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN SEQRES 16 B 243 HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS SEQRES 17 B 243 ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SEQRES 18 B 243 SER MET LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU SEQRES 19 B 243 LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 1 C 243 LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA SEQRES 2 C 243 LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR SEQRES 3 C 243 ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY SEQRES 4 C 243 LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET SEQRES 5 C 243 ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU SEQRES 6 C 243 THR SER HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP SEQRES 7 C 243 LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET SEQRES 8 C 243 GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU SEQRES 9 C 243 LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL SEQRES 10 C 243 GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE SEQRES 11 C 243 ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU SEQRES 12 C 243 LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE SEQRES 13 C 243 LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS SEQRES 14 C 243 ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE SEQRES 15 C 243 HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN SEQRES 16 C 243 HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS SEQRES 17 C 243 ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SEQRES 18 C 243 SER MET LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU SEQRES 19 C 243 LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 1 D 243 LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA SEQRES 2 D 243 LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR SEQRES 3 D 243 ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY SEQRES 4 D 243 LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET SEQRES 5 D 243 ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU SEQRES 6 D 243 THR SER HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP SEQRES 7 D 243 LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET SEQRES 8 D 243 GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU SEQRES 9 D 243 LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL SEQRES 10 D 243 GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE SEQRES 11 D 243 ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU SEQRES 12 D 243 LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE SEQRES 13 D 243 LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS SEQRES 14 D 243 ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE SEQRES 15 D 243 HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN SEQRES 16 D 243 HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS SEQRES 17 D 243 ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SEQRES 18 D 243 SER MET LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU SEQRES 19 D 243 LEU LEU GLU MET LEU ASP ALA HIS ARG HET 29S A 601 35 HET 29S B 601 35 HET 29S C 601 35 HET 29S D 601 35 HETNAM 29S BAZEDOXIFENE HETSYN 29S 1-{4-[2-(AZEPAN-1-YL)ETHOXY]BENZYL}-2-(4- HETSYN 2 29S HYDROXYPHENYL)-3-METHYL-1H-INDOL-5-OL FORMUL 5 29S 4(C30 H34 N2 O3) FORMUL 9 HOH *39(H2 O) HELIX 1 AA1 LEU A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 ASP A 321 1 11 HELIX 3 AA3 MET A 342 LYS A 362 1 21 HELIX 4 AA4 THR A 371 ARG A 394 1 24 HELIX 5 AA5 ARG A 412 LYS A 416 1 5 HELIX 6 AA6 MET A 421 MET A 438 1 18 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 THR A 465 ALA A 493 1 29 HELIX 9 AA9 THR A 496 MET A 528 1 33 HELIX 10 AB1 SER A 536 ASP A 545 1 10 HELIX 11 AB2 THR B 311 ASP B 321 1 11 HELIX 12 AB3 SER B 338 LYS B 362 1 25 HELIX 13 AB4 THR B 371 SER B 395 1 25 HELIX 14 AB5 ARG B 412 LYS B 416 1 5 HELIX 15 AB6 GLY B 420 MET B 438 1 19 HELIX 16 AB7 GLN B 441 SER B 456 1 16 HELIX 17 AB8 LEU B 466 ALA B 493 1 28 HELIX 18 AB9 THR B 496 LYS B 529 1 34 HELIX 19 AC1 SER B 536 ASP B 545 1 10 HELIX 20 AC2 THR C 311 ASP C 321 1 11 HELIX 21 AC3 SER C 338 LYS C 362 1 25 HELIX 22 AC4 THR C 371 ARG C 394 1 24 HELIX 23 AC5 ARG C 412 LYS C 416 1 5 HELIX 24 AC6 GLY C 420 MET C 438 1 19 HELIX 25 AC7 GLN C 441 SER C 456 1 16 HELIX 26 AC8 LEU C 466 ALA C 493 1 28 HELIX 27 AC9 THR C 496 MET C 528 1 33 HELIX 28 AD1 SER C 536 ASP C 545 1 10 HELIX 29 AD2 LEU D 306 LEU D 310 5 5 HELIX 30 AD3 THR D 311 ASP D 321 1 11 HELIX 31 AD4 MET D 342 LYS D 362 1 21 HELIX 32 AD5 THR D 371 ARG D 394 1 24 HELIX 33 AD6 ARG D 412 LYS D 416 1 5 HELIX 34 AD7 GLY D 420 MET D 438 1 19 HELIX 35 AD8 GLN D 441 SER D 456 1 16 HELIX 36 AD9 ASP D 473 GLY D 494 1 22 HELIX 37 AE1 THR D 496 MET D 528 1 33 HELIX 38 AE2 SER D 536 MET D 543 1 8 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 408 N ALA A 405 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 SHEET 1 AA3 2 LYS C 401 LEU C 403 0 SHEET 2 AA3 2 LEU C 409 ASP C 411 -1 O LEU C 410 N LEU C 402 SHEET 1 AA4 2 LYS D 401 ALA D 405 0 SHEET 2 AA4 2 LEU D 408 ASP D 411 -1 O LEU D 408 N ALA D 405 CISPEP 1 ARG B 335 PRO B 336 0 4.81 CISPEP 2 ARG C 335 PRO C 336 0 5.49 SITE 1 AC1 13 LEU A 346 THR A 347 ASP A 351 GLU A 353 SITE 2 AC1 13 LEU A 391 ARG A 394 PHE A 404 ILE A 424 SITE 3 AC1 13 HIS A 524 LEU A 525 ASN A 532 VAL A 533 SITE 4 AC1 13 PRO A 535 SITE 1 AC2 16 LEU B 346 THR B 347 ALA B 350 ASP B 351 SITE 2 AC2 16 GLU B 353 LEU B 354 TRP B 383 LEU B 387 SITE 3 AC2 16 LEU B 391 ARG B 394 ILE B 424 GLY B 521 SITE 4 AC2 16 HIS B 524 LEU B 525 VAL B 533 PRO B 535 SITE 1 AC3 12 LEU C 346 THR C 347 ASP C 351 GLU C 353 SITE 2 AC3 12 MET C 388 ARG C 394 ILE C 424 HIS C 524 SITE 3 AC3 12 LEU C 525 ASN C 532 VAL C 533 HOH C 706 SITE 1 AC4 22 ALA D 350 ASP D 351 GLU D 353 LEU D 354 SITE 2 AC4 22 TRP D 383 LEU D 387 LEU D 391 ARG D 394 SITE 3 AC4 22 GLU D 419 GLY D 420 MET D 421 ILE D 424 SITE 4 AC4 22 LYS D 520 GLY D 521 MET D 522 GLU D 523 SITE 5 AC4 22 LEU D 525 TYR D 526 SER D 527 MET D 528 SITE 6 AC4 22 ASN D 532 PRO D 535 CRYST1 53.575 59.165 94.144 86.76 75.36 63.03 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018665 -0.009496 -0.005528 0.00000 SCALE2 0.000000 0.018964 0.001280 0.00000 SCALE3 0.000000 0.000000 0.011003 0.00000